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Background: There has been little focus lately on operative techniques for full graft liver transplantation,
and the standard technique is unclear.
Methods: An internet survey addressing the key technical issues was e-mailed to programme directors.
Results: Responses were obtained from 93 out of 128 (73%) directors contacted. Programmes per-
formed a median of 60 (8–240) transplants per year. Maximum mean cold time of 13  3 h and maximum
median steatosis of 40% (15–90%) were tolerated. The inferior vena cava was preserved by 48% of
centres all the time and 43% selectively. European centres used temporary portacaval shunting (42%)
four times more often than USA programmes. Venous bypass was always used when not preserving the
inferior vena cava by less than 25%, and used selectively by approximately 40% of centres. Portal vein
anastomosis with room for expansion (88%), graft hepatic artery to native gastroduodenal/common
hepatic artery bifurcation (57%) and bile duct-to-duct (47%) were the favoured techniques.
Discussion: A standard international operative technique for deceased donor liver transplantation does
not exist, although there is a trend towards inferior vena cava preservation. Donor selection criteria were
more homogenous across programmes. As suggested by the high response rate, there likely exists
interest to investigate technical variations on an international scale.
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Introduction
There are upwards of 320 centres worldwide performing adult
deceased donor liver transplantation. Most of these centres are
in Western Europe (137), North America (116), and South and
Central America (76).1–4 The number of transplantation
programmes in Asia performing adult deceased donor liver
transplantation is difficult to determine, given their preference
for living donation. Similar to other aspects of surgery,
this probably remains a heterogeneous field with variations
in staffing and techniques for organ recovery and transplanta-
tion based on the regulations, customs and constraints of
different health care systems and individual institutions.
Improved survival with decreased morbidity is the underlying
objective of all practices, but best practices are always evolving.
In recent years, technical reports in the literature concerning
orthotopic liver transplantation in adults have mainly focused on
living donor and split liver practices. Furthermore, in the abun-
dance of transplant literature, the trends in different regions of the
world are not always clear. An international survey was conducted
to investigate whether a standard technique exists for deceased
donor liver transplantation in adults.
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Methods
A 40-question survey was designed to address staffing, organ
recovery, transplant hepatectomy, transplant reconstruction and
abdominal closure (Fig. 1). Five of the questions pertained to
programme characteristics (Fig. 1: Center: Country & City &
Hospital & Surgical director & email). The survey was purpose-
fully brief and queried information that would be readily available
without the need for independent data searching. At the same
time, it addressed key technical issues in transplantation.
Programme directors of all centres in Europe, North, South and
Central America, Africa, Australia and New Zealand, and the
Middle East performing deceased donor adult liver transplanta-
tion and listing their e-mail address on the internet were invited to
participate. An active link to the secure website was included in an
explanatory e-mail, and participants completed the survey
on-line. Asian centres were not contacted for this survey because
of the rarity of deceased donor transplantation. A period of 2
weeks and then 2 months passed before reminder e-mails were
sent to non-responders, and data were collated 1 month later.
Data are presented as mean SD and median (range) based on
the normality of the distribution for a given variable, or number
of respondents (percentage). Given the variable number of
responses from each country and continent, differences of statis-
tical significance were not calculated. Three questions were
excluded from the final analysis because of a less than 75%
response rate suggesting they were unclear to the respondents
(Fig. 1: Graft: split liver type, living donor type & minimal graft/
body weight ratio). One question was excluded to prevent com-
mercial bias (Fig. 1: Hepatectomy: type of retractor). Two
variables asking for specific details about a previous response were
combined with the root variable (Fig. 1: Graft: preservation solu-
tion, specify; Reconstruction: inferior vena cava (IVC) preserva-
tion graft implantation, specify).
Results
One hundred twenty-eight emails were sent [Europe: 60; United
States of America (USA): 50; South America: 5; Africa: 4;
Australia/New Zealand: 6; Israel: 3] and 93 (73%) replies were
received. After exclusion of the three questions deemed confusing,
2.9% of total responses were missing. For the analyses, centres
were stratified as belonging to Europe, USA, or Other. The last
group included three South American, two Middle East, one
Australian and one African programme. Most programmes were
greater than 20 years old (range 2–46), and performed a median of
60 liver transplants per year (range 8–240) (Table 1). For all pro-
grammes considered, the mean number of attending transplant
surgeons was 4  2 (range 1–10). A mean of 2  1 assistants per
transplant aided the operating surgeon at European and other
centres, whereas surgeons at USA centres more likely had a single
assistant (1  1).
Table 1 provides data regarding graft selection preferences and
preservation solutions utilized. The mean maximum age of
deceased donors accepted by centres was 82  9, and six Euro-
pean and two centres in the USA did not have a maximum age
for donation. Programmes in the Other category had a lower
mean maximum tolerated donation age than centres in Europe
and USA. The mean acceptable cold ischaemia time was within
1 h across the centres (13  2–14  4). The median percent
macrovesicular steatosis of deceased donors accepted by centres
was higher in European (50%) than USA (33%) centres.
Donation after cardiac death was utilized more often in the USA
(84% vs. 42% for all programmes). Split liver grafts were utilized
by 85% of the total centres surveyed. The use of extracellular,
intracellular or both types of solutions was evenly distributed
among European programmes, while a strong trend towards
intracellular solutions in the USA and Other programmes was
observed.
The inverted ‘T’ and bilateral subcostal incisions were most
often used for transplantation (Table 2). Forty-two per cent of
European programmes made use of temporary portacaval shunt-
ing as opposed to 10% of USA centres. Preservation of the inferior
Figure 1 The Survey on Adult Liver Transplantation Technique (SALT)
was a 40-item survey completed on a secure website covering the
key technical issues in deceased donor liver transplantation
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vena cava was standard in more than half the European centres
(57%), with only 38% of USA and Other centres using this tech-
nique (Fig. 2). If the recipient inferior vena cava was preserved,
the overwhelming majority (80%) never used venous–venous
bypass, whereas if the inferior vena cava was resected, 65% always
or sometimes utilized venous–venous bypass (Fig. 3).
Table 2 informs on the vascular and biliary reconstruction.
Overall, the piggy-back three-hepatic vein to inferior vena cava
anastomosis (39%) was favoured to the two-hepatic vein tech-
nique (26%), although the two-hepatic vein was marginally more
popular than the three-vein technique in the USA. A side-to-side
technique was performed by 28% of centres. The portal anasto-
mosis was most often performed with a running suture (92%),
with the majority of centres favouring a growth factor for expan-
sion after reperfusion (88%). Anastomosis of the graft hepatic
artery to the native common hepatic and gastroduodenal artery
bifurcation (57%) was favoured over the hepatic artery to hepatic
artery technique (43%). Again, a running suture was preferred
(82%). Ninety percent of centres re-vascularized the portal vein
before the hepatic artery. For the bile duct, using interrupted
sutures (47%) to perform a duct-to-duct anastomosis without the
use of a T-tube (81%) was the trend.
Drainage was used at 86% of the centres, with two or more
drains being the most common practice (Table 2). The abdominal
wall was most often closed with a continuous (88%), absorbable
(86%) suture and skin was most often closed with staples (74%).
Discussion
Orthotopic liver transplantation has become so widely accepted
and practiced that recent literature rarely reports on the technical
aspects of the operation, but rather focuses on peri-operative care
and partial grafts (i.e. living donor and split grafts). An interna-
tional internet survey was performed in order to categorize
current practices in deceased donor liver transplantation and
determine if a standard operation was performed. The overall
response rate over a 2-month period with two reminder e-mails
was 73%, with an item completion rate of over 97%. This is better
than other recent mail surveys (19%–67%) within the transplant
community.4,5 This suggests the survey was well understood by
Table 1 Programme characteristics
All Europe USA Othera
Number of programmes 93 51 34 8
Programme characteristicsb
Years transplanting 20  8 20  8 19  8 21  10
Total liver transplants, median (range) 938 (145–8643) 700 (164–3182) 1250 (153–8643) 563 (145–1100)
Liver transplants per year, median (range) 60 (8–240) 53 (20–160) 100 (37–240) 32 (8–140)
Number of attending transplant surgeons 4  2 4  2 5  2 4  1
Number of assistants during transplant 2  1 2  1 1  1 2  1
Graft characteristicsb
Maximum accepted donor age, years 82  9 81  8 84  9 76  14
Maximum tolerated cold ischaemia time, hours 13  3 13  3 14  4 13  2
Maximum % tolerated macro-steatosis, median (range) 40 (15–90) 50 (15–90) 33 (20–60) 45 (20–80)
Donation after cardiac death, respondents (%)
Do not recover 53 (58) 41 (80) 5 (16) 7 (88)
Maastricht I 8 (9) 1 (2) 7 (22) 0
Maastricht II 5 (5) 2 (4) 3 (9) 0
Maastricht II or IV 1 (1) 1 (2) 0 0
Maastricht III 16 (18) 3 (6) 12 (37) 1 (12)
Maastricht III or IV 7 (8) 3 (6) 4 (12) 0
Maastricht IV 1 (1) 0 1 (3) 0
Perform split liver transplants 79 (85) 45 (88) 28 (82) 6 (75)
Perform living related liver transplants 64 (70) 33 (67) 24 (71) 7 (88)
Preservation solutions, respondents (%)
Extracellular solution 25 (27) 18 (35) 7 (20) (0)
Intracellular solution 44 (47) 15 (30) 23 (68) 6 (75)
Intracellular and extracellular solutions 24 (26) 18 (35) 4 (12) 2 (25)
aAustralia, Brazil, Chili, Israel, South Africa.
bmean  SD unless otherwise noted.
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Table 2 Surgical techniques for deceased donor liver transplantationa
All Europe USA Other
Number of programmes 93 51 34 8
Hepatectomy
Incision
Bilateral subcostal or inverted T Incision 64 (70) 36 (72) 24 (73) 4 (50)
J-shaped incision 27 (30) 14 (28) 9 (27) 4 (50)
Temporary porta-caval anastomosis 22 (27) 19 (42) 3 (10) 0
Transplantation
IVC preservation graft implantation
Piggy-back 2-hepatic veins 23 (26) 7 (15) 13 (43) 3 (38)
Piggy-back 3-hepatic veins 34 (39) 19 (39) 12 (40) 3 (38)
Side-to-side 24 (28) 17 (35) 5 (17) 2 (24)
Other 6 (7) 6 (11) 0 0
Portal anastomosis
Posterior running and anterior interrupted 7 (8) 7 (14) 0 0
Running 81 (92) 43 (86) 31 (100) 7 (100)
Growth factor 73 (88) 36 (78) 29 (100) 8 (100)
Arterial anastomosis
Preferred arterial implantation site
Hepatic artery 38 (43) 21 (44) 14 (44) 3 (37)
Hepatic/gastroduodenal artery confluence 50 (57) 27 (56) 18 (56) 5 (63)
Artery implantation technique
Interrupted 9 (10) 5 (10) 3 (10) 1 (12)
Posterior running & anterior interrupted 7 (8) 3 (6) 1 (3) 3 (38)
Running 73 (82) 42 (84) 27 (87) 4 (50)
Artery implantation if aorta
Infra-renal 36 (51) 18 (49) 12 (44) 6 (86)
Supra-celiac 12 (17) 4 (11) 8 (30) 0
Infra-renal or supra-celiac 23 (32) 15 (40) 7 (26) 1 (14)
Order of graft revascularization
Portal vein first 70 (90) 45 (92) 28 (88) 7 (88)
Portal vein & hepatic artery simultaneously 7 (8) 2 (4) 4 (12) 1 (12)
Hepatic artery first 2 (2) 2 (4) 0 0
Bile duct anastomosis
Bile duct standard reconstruction
Duct-to-duct with T-tube 17 (19) 13 (27) 3 (10) 1 (12)
Duct-to-duct without T-tube 71 (81) 36 (73) 28 (90) 7 (88)
Bile duct reconstruction technique
Interrupted 40 (47) 21 (47) 15 (48) 4 (50)
Posterior running & anterior interrupted 9 (11) 6 (13) 1 (4) 2 (25)
Running 35 (42) 18 (40) 15 (48) 2 (25)
Closure
Abdominal drainage
No drains 12 (14) 7 (14) 5 (17) 0
1 drain 20 (22) 14 (27) 5 (17) 1 (12)
2 drains 57 (64) 30 (59) 20 (66) 7 (88)
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programme directors and that queried topics were relevant. This
high response rate can be interpreted as attestation that these
technical issues are of importance to transplant surgeons.
Although the range was wide, the responding centres had
lengthy transplant experience and performed on average, 1–20
transplants per month depending on the geographical region.
European and USA data may be more representative of their
regions, as these centres were easily indentified on the internet and
through registry organizations.1,2 The same was not true for other
regions of the world. The responding USA programmes tended to
have more attending surgeons than the European and Other
centres, but utilized 1-less operative assistant. The increased staff-
ing is probably reflective of the larger transplant volume of the
USA centres that were surveyed. The difference in operative assis-
tants may be impacted by the design of surgical training pro-
grammes in Europe and the USA.
With regard to graft preferences, there were some small varia-
tions across the results, but the overall trends were for centres
not to accept grafts from donors older than 81 years of age, with
cold ischaemia times greater than 13 h and with macrovesicular
steatosis greater than 44%. Donation after cardiac death was
more frequently utilized in the United States. This is probably
secondary to the available resources to perform transplantation
in the setting of a wide discrepancy between listed patients
and available organs, and legal and ethical differences across
nations, especially with regard to Maastricht 3 (i.e. controlled
donation after cardiac death) organ recovery. There was a strong
trend towards intracellular conservation solutions in the USA
and Other programmes, whereas there was a fairly even
distribution in Europe among extracellular, intracellular
and both types of solutions. As multiple randomized studies of
University of Wisconsin, histidine–tryptophan–ketoglutarate
and Celsior have shown the solutions to be similar with regard
to graft preservation, the significance of these different utiliza-
tion practices are unclear and may be customary and price
driven.
Table 2 Continued
All Europe USA Other
Fascia closure
Continuous suture 78 (88) 42 (84) 28 (90) 8 (100)
Interrupted sutures 8 (9) 5 (10) 3 (10) 0
Combination of continuous and interrupted sutures 3 (3) 3 (6) 0 0
Absorbable suture 53 (86) 29 (83) 19 (91) 5 (83)
Monofilament 48 (89) 25 (83) 19 (100) 4 (80)
Skin closure
Interrupted 5 (6) 5 (10) 0 0
Running 14 (16) 8 (16) 3 (9) 3 (37)
Staples 67 (74) 33 (66) 29 (91) 5 (63)
Staples and suture 4 (4) 4 (8) 0 0
aNumber of respondents (% of responses).
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Figure 2 Preservation of the recipient inferior vena cava (IVC) for deceased donor liver transplantation
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Although always preserving the IVC was more common among
European centres, greater than 50% of the USA and Other pro-
grammes either always or selectively preserved the IVC. Construc-
tion of a temporary portacaval shunt was used more often in
Europe. Venous bypass was used in about 25% of centres not
preserving the IVC and interestingly used in some USA centres in
association with IVC preservation. For the IVC anastomosis, the
piggy-back technique followed by the side-to-side technique was
favoured overall when the IVC was preserved. In the United States,
the piggy-back 3- and 2-hepatic vein techniques were similarly
used whereas the piggy-back 3-hepatic vein and side-to-side tech-
niques were the more common practices in Europe.
The present study was descriptive. The aim was to survey
current practices and not correlate outcomes. The latter was
intentionally avoided because it would lack scientific validity in
this non-controlled survey. This study provides surgeons with
insight into where their practices stand technically on a worldwide
and regional scale. Although it can be argued that the surveyed
data represent the practices of programme directors and not pro-
grammes, most directors continue to be the technical, thought
and educational leaders in the field, and their practices are not
easily discredited.
Although there is heterogeneity in the techniques used, particu-
larly in the preservation of the IVC, the use of temporary porta-
caval shunting and venous bypass, there appears to be an
international trend towards IVC preservation. The present study
does not have the power to explain the variations in technical
practices between countries and between centres within countries.
These are likely explained by training, institutional history and
geographical origin. Other variables were more homogeneous
including donor selection, cold ischaemia times and the degree of
graft macrovesicular steatosis, which probably have a greater
impact on outcomes.
In conclusion, an intentionally brief survey was developed to
assess the technical practices of centres performing deceased
donor orthotopic liver transplantation in adults. Based on these
findings, liver recovery and transplantation operations appear to
share some characteristics around the world, but there remains
some key trends in practice that differ by region. As suggested by
the high survey response rate, there probably exists strong interest
to investigate the impact of technical variations demonstrated in
this survey on an international scale.
Acknowledgements
The authors thank the following institutions and program directors for their
participation:
Australia: Brisbane, Princess Alexandra Hospital (J. Fawcet); Sydney, Royal
Prince Alfred Hospital (Crawford). Austria: Innsbruck, University Hospital (R.
Margreiter). Belgium: Leuven, Uz Gasthuisberg (J. Pirenne). Brazil: Sao Paulo,
Clinical Hospital, Sao Paulo University (L. D'Albuquerque); Sao Paulo, Instituto
Dante Pazzanese (S. Mies). Chile: Santiago, Clinica Alemana (J. Hepp).
England: Birmingham, Queen Elizabeth (J. Buckels); Cambridge, Adden-
brookes (N. Jamieson). France: Caen, University Hospital (L. Chiche & E.
Selame); Creteil, Henri Mondor Hospital (D. Cherqui); Grenoble, CHU Michal-
lon (C. Letoublon); Lille, Huriez – CHRU de Lille (F.R. Pruvot); Lyon, Croix
Always
Selected
Never
0%
10%
20%
30%
40%
C
en
tr
es
 s
ur
ve
ye
d
50%
41% 41%
47%
66%
24%
35% 33% 30%
17% 17%
26% 23%
60%
70%
All Europe USA Other
Always
Selected
Never
0%
20%
40%
60%
80%
100%
120%
C
en
tr
es
 s
ur
ve
ye
d 80%
100%
7%13%
84%
69%
0%0%
8%8%
24%
7%
All Europe USA Other
Figure 3 Utilization of bypass if the recipient inferior vena cava (IVC) is resected (top) and preserved (bottom) during deceased donor liver
transplantation
HPB 697
HPB 2011, 13, 692–698 © 2011 International Hepato-Pancreato-Biliary Association
Rousse Hospital (C. Ducerf); Lyon, Edouard Herriot Hospital (O. Boillot);
Marseille, La Conception Hospital (Y.P. Le Treut); Paris, Cochin Hospital (O.
Soubrane); Paris, Beaujon Hospital (J. Belghiti); Rennes, Pontchaillou Hospital
(K. Boudjema); Strasbourg, CHU Hautepierre (P. Wolf & D. Jaeck); Toulouse,
Rangueil Hospital (B. Suc); Villejuif, Paul Brousse Hospital (D. Castaing).
Germany: Berlin, Charite Berlin (P. Neuhaus); Bonn, Uniklinikum (A. Hirner);
Essen, University Hospital Essen (C. Broelsch); Hannover, Medical School
Hannover (J. Klempnauer); Munich, LMU, Großhadern (H. Mult & K. Jauch);
Munster, University Clinic (N. Senninger); Tuebingen, University Hospital (A.
Konigsrainer & S. Nadalin). Israel: Tel Aviv, Sourasky Medical Center (R.
Nakache); Tel Aviv, Tel Aviv Medical Center (M. Ben-Haim). Italy: Bergamo,
Ospedali Riuniti (M. Colledan); Bologna, Sant'Orsola (A. Pinna); Milan, Istituto
Nazionale Tumori (V. Mazzaferro); Milan, Policlinico-Ospedale Maggiore (G.
Rossi); Milan, Niguarda (L. DeCarlis); Palermo, ISMETT-UPMC (B. Gridelli);
Rome, La Sapienza University (M. Rossi & P. Berloco); Rome, San Camillo (G.
Ettorre); Udine, University of Udine School of Medicine (F. Bresadola).
Netherlands: Groningen, University Medical Center Groningen (R. Porte);
Leiden, Leiden University Medical Centre (J. Ringers); Rotterdam, Erasmus
Medical Center (G. Kazemier). Poland: Warsaw, Medical University of Warsaw
(M. Krawyczk). Portugal: Porto, Santo Antonio (V. Ribeiro). Romania: Bucha-
rest, Fundeni Institute (I. Popescu). Scotland: Edinburgh, Royal Infirmary (J.
Forsythe). South Africa: Cape Town, University of Cape Town (D. Kahn).
Spain: Barcelona, Hospital Clinic (J.C. Garcia-Valdecasas); Cordoba, HU
Reina Sofia (P. Lopez-Cillero); La Coruna, CHU Juan Canalejo (G. Gutierrez);
Madrid, H. Gregorio Maranon (C. Kempin); Malaga, Carols Haya (J. Santoyo);
Oviedo, Universitario Central de Asturias (I. Gonzalez-Pinto); Pamplona,
Clinica Universitaria (F. Pardo). Sweden: Oslo, Rikshospitalet (A. Foss); Stock-
holm, Karolinska Institutet (B. Ericzon). Switzerland: Zurich, University Hos-
pital (P. Clavien). Turkey: Izmir, Ege University (M. Klic). United States of
America: Ann Arbor, Michigan, University of Michigan Medical Center (S.
Pelletier); Baltimore, Maryland, Johns Hopkins Hospital (R. Montgomery); Bur-
lington, Massachusetts, Lahey Clinic (E. Pomfret); Charleston, South Carolina,
Medical University of South Carolina (P. Baliga); Charlotte, North Carolina,
Carolinas Medical Center (L. Eskind); Chicago, Illinois, University of Chicago
(G. Testa); Cleveland, Ohio, Cleveland Clinic Foundation (C. Miller); Dallas,
Texas, Baylor University Medical Center (G. Klintmalm); Detroit, Michigan,
Henry Ford Hospital (M. Abouljoud); Durham, North Carolina, Duke University
Hospital (D. Sudan); Gainesville, Florida, University of Florida at Shands (A.
Hemming); Houston, Texas, St. Luke's Episcopal Hospital (J. Gross); India-
napolis, Indiana, Indiana University Hospital (J. Tector); Los Angeles, Califor-
nia, Cedars-Sinai Medical Center (S. Colquhoun); Jacksonville, Florida, Mayo
Clinic in Florida (J. Hguyen); Los Angeles, California, U. of California at Los
Angeles Medical Center (R. Busuttil); Louisville, Kentucky Jewish Hospital (M.
Marvin); Memphis, Tennessee, Methodist University Hospital (J. Eason);
Miami, Florida, Jackson Memorial Hospital (A. Tzakis); Minneapolis, Minne-
sota, University of Minnesota Medical Center (W. Payne); Nashville, Tennes-
see, Vanderbilt University Medical Center (J.K. Wright); New Orleans,
Louisiana, Ochsner Medical Center (G. Loss); New York, New York, Mount
Sinai Medical Center (J. del Rio Martin); New York, New York, NYPH-Columbia
University Medical Center (T. Kato & J. Emond); Omaha, Nebraska, University
of Nebraska Medical Center (A. Langnas); Orlando, Florida, Florida Hospital
Medical Center (L.T. Chin); Philadelphia, Pennsylvania, Medical Center of the
University of Philadelphia (K. Olthoff); Phoenix, Arizona, Banner Good Samari-
tan Medical Center (J. Cashman); Pittsburgh, Pennsylvania, University of
Pittsburgh Medical Center (P. Fontes); Rochester, Minnesota, Mayo Clinic-
Rochester Methodist Hospital (C. Rosen); Rochester, New York, Strong
Memorial Hospital (M. Orloff); San Francisco, California, U. of California San
Francisco Medical Center (J. Roberts); St. Louis, Missouri, Barnes-Jewish
Hospital (W. Chapman); Tampa, Florida, Tampa General Hospital (A. Alsina).
Conflicts of interest
None declared.
References
1. European Liver Transplant Registry. List of participating centers. Available
at http://www.eltr.org/spip.php?page=centers-tous (accessed 25 February
2010).
2. United Network of Organ Sharing. (2010) Member directory: transplant
centers by organ, liver, all states. Available at http://optn.
transplant.hrsa.gov/members/search.asp (Accessed 25 February 2010).
3. Hepp J, Innocenti FA. (2004) Liver transplantation in Latin America: current
status. Transplant Proc 36:1667–1668.
4. Kroeker KI, Bain VG, Shaw-Stiffel T, Fong TL, Yoshida EM. (2008) Adult
liver transplant survey: policies towards eligibility criteria in Canada and the
United States 2007. Liver Int 28:1250–1255.
5. Shiffman ML, Rockey DC. (2008) Role and support for hepatologists at liver
transplant programs in the United States. Liver Transpl 14:1092–1099.
698 HPB
HPB 2011, 13, 692–698 © 2011 International Hepato-Pancreato-Biliary Association
